| Merck & Co., Inc. | North Carolina | state | 2004 | $24,000,000 | | grant/loan hybrid program |
| Merck, Sharp & Dohme Corp. | Pennsylvania | state | 2011 | $19,590,893 | | tax credit/rebate |
| Merck Sharp & Dohme Corp. | North Carolina | state | 2015 | $12,098,272 | | tax credit/rebate |
| Merck, Sharp & Dohme Corp. | Pennsylvania | state | 2012 | $10,263,039 | | tax credit/rebate |
| Merck & Co., Inc. | Virginia | state | 2019 | $7,500,000 | | grant |
| Merck & Co., Inc. | North Carolina | state | 2012 | $6,651,352 | | tax credit/rebate |
| Merck & Co., Inc. | North Carolina | state | 2010 | $6,007,498 | | tax credit/rebate |
| Merck & Co., Inc. | Texas | state | 2017 | $6,000,000 | | grant |
| Merck Sharp & Dohme Corp. | North Carolina | state | 2004 | $5,514,655 | | grant |
| Merck Sharp & Dohme Corp. II | North Carolina | state | 2019 | $4,974,750 | | grant |
| Merck Sharp & Dohme Corp. | North Carolina | state | 2016 | $4,302,041 | | tax credit/rebate |
| Intervet Inc. | New Jersey | state | 2012 | $3,981,600 | | grant |
| Merck & Co. Inc. | New Jersey | state | 2000 | $3,948,650 | | grant |
| Merck & Co., Inc. | North Carolina | state | 2008 | $2,940,954 | | tax credit/rebate |
| Merck & Co., Inc. | North Carolina | state | 2011 | $2,774,342 | | tax credit/rebate |
| Merck Sharp & Dohme Corp. | North Carolina | state | 2017 | $2,511,374 | | tax credit/rebate |
| Merck Sharp & Dohme Corp. | North Carolina | state | 2018 | $2,189,941 | | tax credit/rebate |
| MERCK SHARP & DOHME CORP | Pennsylvania | state | 2020 | $1,759,300 | | tax credit/rebate |
| Merck & Co., Inc. | Pennsylvania | state | 2009 | $1,677,793 | | tax credit/rebate |
| Merck & Co., Inc. | North Carolina | state | 2009 | $1,579,355 | | tax credit/rebate |
| Merck | Virginia | state | 2007 | $1,500,000 | | grant |
| Merck | Virginia | state | 2015 | $1,500,000 | | grant |
| Merck, Sharp & Dohme Corp. | Pennsylvania | state | 2010 | $1,321,420 | | tax credit/rebate |
| Merck Sharpe & Dohme | Virginia | state | 2016 | $1,300,000 | | grant |
| Merck & Co | Virginia | state | 2016 | $1,300,000 | | grant |
| Merck | Virginia | state | 2019 | $1,300,000 | | grant |
| Merck Sharp & Dohme Corp. | North Carolina | state | 2013 | $1,230,023 | | tax credit/rebate |
| Merck & Co., Inc. | Pennsylvania | state | | $1,200,000 | | grant |
| Cherokee Pharmaceuticals, LLC | Pennsylvania | state | | $1,200,000 | | grant |
| Merck Animal Health | Louisiana | state | 2012 | $995,624 | | property tax abatement |
| Merck & Co., Inc. | Pennsylvania | state | 2010 | $937,650 | | grant |
| Merck & Co., Inc. | New Jersey | state | 1999 | $874,000 | | grant |
| Merck & Co., Inc. | North Carolina | state | 2008 | $770,277 | | tax credit/rebate |
| Merck & Co., Inc. | Pennsylvania | state | | $735,000 | | training reimbursement |
| Cherokee Pharmaceuticals, LLC | Pennsylvania | state | | $699,000 | | tax credit/rebate |
| Merck Sharp & Dohme Corporation | North Carolina | state | 2010 | $655,234 | | tax credit/rebate |
| Merck Sharp & Dohme Corp. | North Carolina | state | 2015 | $521,964 | | tax credit/rebate |
| C3i, Inc. | Pennsylvania | state | | $512,000 | | tax credit/rebate |
| C3i, Inc. | Pennsylvania | state | 2014 | $512,000 | | tax credit/rebate |
| Merck, Sharp & Dohme Corp. | Pennsylvania | state | 2017 | $506,455 | | tax credit/rebate |
| C3i, Inc. | Pennsylvania | state | | $500,000 | | grant |
| Intervet, Inc. D/B/A Merck | Nebraska | state | 2019 | $500,000 | | grant |
| Merck | Virginia | state | 2007 | $500,000 | | grant |
| C3i Incorporated | Pennsylvania | state | | $458,000 | | tax credit/rebate |
| Merck & Co., Inc. | North Carolina | state | 2008 | $452,785 | | tax credit/rebate |
| Merck (2015) | Virginia | state | 2016 | $450,000 | | training reimbursement |
| Merck (2015) | Virginia | state | 2017 | $450,000 | | training reimbursement |
| C3i Incorporated | Pennsylvania | state | | $400,000 | | grant |
| Merck Sharp & Dohme Corporation | North Carolina | state | 2011 | $343,194 | | tax credit/rebate |
| Merck Sharp & Dohme Corporation | North Carolina | state | 2009 | $330,681 | | tax credit/rebate |
| Merck & Co., Inc. | North Carolina | state | 2006 | $295,263 | | tax credit/rebate |
| Merck & Co., Inc. | Pennsylvania | state | | $265,000 | | training reimbursement |
| Merck & Co., Inc. | North Carolina | state | 2012 | $220,500 | | tax credit/rebate |
| Merck Sharp & Dohme Corporation | North Carolina | state | 2013 | $213,102 | | tax credit/rebate |
| Merck Manufacturing (project 6) | North Carolina | state | 2022 | $167,242 | | training reimbursement |
| Merck & Co., Inc. | North Carolina | state | 2012 | $160,804 | | tax credit/rebate |
| Merck Manufacturing (project 6) | North Carolina | state | 2023 | $145,971 | | training reimbursement |
| Merck Sharp & Dohme Corporation | North Carolina | state | 2012 | $138,942 | | tax credit/rebate |
| Merck & Co., Inc. | North Carolina | state | 2012 | $130,000 | | tax credit/rebate |
| IMMUNE DESIGN CORP. | Washington | state | 2017 | $115,926 | | tax credit/rebate |
| IMMUNE DESIGN CORP. | Washington | state | 2018 | $115,926 | | tax credit/rebate |
| Merck & Co., Inc. | North Carolina | state | 2008 | $99,344 | | tax credit/rebate |
| Merck & Co., Inc. | Virginia | state | 2010 | $89,383 | | training reimbursement |
| Schering Corporation | Florida | state | 2007 | $84,000 | | tax credit/rebate |
| Merck & Co., Inc. | North Carolina | state | 2007 | $78,855 | | tax credit/rebate |
| Merck & Co., Inc. | North Carolina | state | 1999 | $67,000 | | grant |
| Merck & Co., Inc. | North Carolina | state | 2011 | $55,000 | | tax credit/rebate |
| C3I,Incorporated | New York | local | 2002 | $50,592 | | grant |
| Schering-Plough Animal Health Corporation | Delaware | state | 2008 | $45,400 | | training reimbursement |
| Schering-Plough Animal Health Corporation | Delaware | state | 2007 | $43,943 | | training reimbursement |
| Merck & Co., Inc. | North Carolina | state | 2001 | $33,000 | | grant |
| Intervet, Inc. | Delaware | state | 2011 | $29,450 | | training reimbursement |
| Intervet, Inc. | Delaware | state | 2015 | $29,352 | | training reimbursement |
| Intervet, Inc. | Delaware | state | 2016 | $28,919 | | training reimbursement |
| IMMUNE DESIGN CORP | Washington | state | 2014 | $22,572 | | tax credit/rebate |
| Schering-Plough Animal Health Corporation | Delaware | state | 2006 | $21,485 | | training reimbursement |
| Intervet | Delaware | state | 2003 | $19,925 | | training reimbursement |
| Merck (Wilson) (project 3) | North Carolina | state | 2023 | $19,407 | | training reimbursement |
| Merck & Co., Inc. | North Carolina | state | 2011 | $18,000 | | tax credit/rebate |
| Intervet, Inc. | Delaware | state | 2013 | $16,236 | | training reimbursement |
| Inspire Pharmaceuticals, Inc. | North Carolina | state | 2008 | $14,500 | | tax credit/rebate |
| ILLUMIGEN BIOSCIENCES INC | Washington | state | 2004 | $11,367 | | tax credit/rebate |
| IMMUNE DESIGN CORP | Washington | state | 2014 | $10,326 | | tax credit/rebate |
| IMMUNE DESIGN CORP | Washington | state | 2015 | $10,326 | | tax credit/rebate |
| IMMUNE DESIGN CORP | Washington | state | 2016 | $10,326 | | tax credit/rebate |
| IMMUNE DESIGN CORP | Washington | state | 2013 | $9,868 | | tax credit/rebate |
| C3I | New Hampshire | state | 2014 | $9,576 | | training reimbursement |
| C3I, Inc. | New Hampshire | state | 2012 | $9,105 | | training reimbursement |
| C3I | New Hampshire | state | 2015 | $5,908 | | training reimbursement |
| IMMUNE DESIGN CORP | Washington | state | 2012 | $4,408 | | tax credit/rebate |
| ILLUMIGEN BIOSCIENCES INC | Washington | state | 2005 | $4,341 | | tax credit/rebate |
| IMMUNE DESIGN CORP | Washington | state | 2013 | $4,304 | | tax credit/rebate |
| Intervet Inc. | Kansas | state | 2021 | $1,000 | | training reimbursement |
| Cherokee Pharmaceuticals, LLC | Pennsylvania | state | | | $5,000,000 | loan or bond financing |
| Intervet, Inc. | Nebraska | state | 2001 | undisclosed | | tax credit/rebate |
| Intervet, Inc. | Nebraska | state | 2007 | undisclosed | | tax credit/rebate |
| ILLUMIGEN BIOSCIENCES INC | Washington | state | 2006 | undisclosed | | tax credit/rebate |
| OPTIMER PHARMACEUTICALS, INC. | New Jersey | state | | undisclosed | | tax credit/rebate; property tax abatement |
| C3I, INC | California | local | 2012 | undisclosed | | tax credit/rebate |
| Intervet, Inc. | Nebraska | state | 2017 | undisclosed | | tax credit/rebate |
| Intervet Inc. | Kansas | state | 2019 | undisclosed | | grant |
